Shares

15 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2023

Jan 12, 2024

BUY
$3.77 - $8.39 $63,057 - $140,331
16,726 New
16,726 $133,000
Q2 2023

Jul 10, 2023

SELL
$5.86 - $7.93 $152,295 - $206,092
-25,989 Reduced 62.71%
15,456 $93,000
Q1 2023

Apr 28, 2023

BUY
$5.85 - $9.84 $141,745 - $238,423
24,230 Added 140.75%
41,445 $257,000
Q4 2022

Feb 02, 2023

SELL
$6.88 - $9.55 $159,430 - $221,302
-23,173 Reduced 57.38%
17,215 $159,000
Q3 2022

Oct 31, 2022

BUY
$8.19 - $13.2 $19,295 - $31,099
2,356 Added 6.19%
40,388 $382,000
Q2 2022

Jul 29, 2022

SELL
$7.65 - $14.24 $36,559 - $68,052
-4,779 Reduced 11.16%
38,032 $386,000
Q1 2022

Apr 29, 2022

SELL
$13.02 - $20.78 $138,428 - $220,932
-10,632 Reduced 19.89%
42,811 $610,000
Q4 2021

Feb 07, 2022

SELL
$19.35 - $25.54 $499,210 - $658,906
-25,799 Reduced 32.56%
53,443 $1.1 Million
Q3 2021

Nov 01, 2021

BUY
$21.65 - $39.49 $1.72 Million - $3.13 Million
79,242 New
79,242 $1.81 Million
Q2 2021

Aug 12, 2021

SELL
$15.5 - $22.48 $166,671 - $241,727
-10,753 Closed
0 $0
Q1 2021

May 13, 2021

BUY
$14.84 - $22.23 $48,556 - $72,736
3,272 Added 43.74%
10,753 $217,000
Q4 2020

Feb 04, 2021

SELL
$9.4 - $16.7 $405,600 - $720,588
-43,149 Reduced 85.22%
7,481 $113,000
Q3 2020

Nov 09, 2020

BUY
$10.54 - $24.96 $389,790 - $923,070
36,982 Added 270.97%
50,630 $533,000
Q2 2020

Jul 20, 2020

BUY
$21.87 - $33.11 $78,906 - $119,460
3,608 Added 35.94%
13,648 $334,000
Q1 2020

Apr 30, 2020

BUY
$16.25 - $35.28 $163,150 - $354,211
10,040 New
10,040 $242,000

Others Institutions Holding ALEC

About Alector, Inc.


  • Ticker ALEC
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 82,563,904
  • Market Cap $358M
  • Description
  • Alector, Inc., a clinical stage biopharmaceutical company, develops therapies for the treatment of neurodegeneration diseases. Its products include AL001, a humanized recombinant monoclonal antibody, which is in Phase III clinical trial for the treatment of frontotemporal dementia, Alzheimer's, Parkinson's, and amyotrophic lateral sclerosis dise...
More about ALEC
Track This Portfolio

Track Sg Americas Securities, LLC Portfolio

Follow Sg Americas Securities, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Sg Americas Securities, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Sg Americas Securities, LLC with notifications on news.